Idiopathic Membranous Nephropathy Treatment Market , By Drug Class (Alkylating Agents (Cyclophosphamide and Chlorambucil), Cyclic Peptides, Immunosuppressing Agents (Tacrolimus, Mycophenolate Mofetil, and Rituximab), Synthetic Adrenocorticotropic Hormone (ACTH) Analogue, and Others), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy), By Region (North America, Latin America, Europe, Middle East, Asia Pacific, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022-2028
Select a license type that suits your business needs
Single User License
US$ 4,500
US$ 3,500
Three thousand five hundred dollars
Frequently purchased
Multi User License
US$ 7,000
US$ 5,500
Five thousand five hundred dollars
Corporate User License
US$ 10,000
US$ 7,500
Seven thousand five hundred dollars
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients